Related Experiment Videos
MEF up-regulates human beta-defensin 2 expression in epithelial cells
Zhuo Lu1, Kyoung-Ah Kim, Mary Ann Suico
1Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.
FEBS Letters
|March 12, 2004
Summary
Myeloid ELF-1-like factor (MEF) activates human beta-defensin 2 (HBD2) transcription in epithelial cells. MEF binds to the HBD2 promoter, highlighting its role in innate immunity and HBD2 gene regulation.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Human beta-defensin 2 (HBD2) is a key antimicrobial peptide in epithelial tissues, crucial for innate immunity.
- Myeloid ELF-1-like factor (MEF) is implicated in innate immune responses, including the regulation of other immune genes.
Purpose of the Study:
- To investigate the role of MEF in the transcriptional regulation of human beta-defensin 2 (HBD2).
- To elucidate the mechanism by which MEF influences HBD2 expression.
Main Methods:
- Reporter gene assays to assess HBD2 promoter activity.
- Analysis of HBD2 transcription levels following MEF manipulation.
- Electrophoretic mobility shift assays (EMSA) to confirm protein-DNA interaction.
Main Results:
- MEF significantly activated HBD2 promoter activity and increased endogenous HBD2 transcription.
- Antisense MEF RNA and mutation of the ETS binding site (EBS) in the HBD2 promoter attenuated MEF-induced activation.
- EMSA confirmed direct binding of MEF to the EBS in the HBD2 promoter.
Conclusions:
- MEF plays a significant role in regulating HBD2 expression in epithelial cells.
- MEF directly interacts with the HBD2 promoter via the EBS to drive HBD2 transcription.
- These findings reveal a novel regulatory pathway in the innate immune response involving MEF and HBD2.